Načítá se...

Oroxylin A, but Not Vasopressin, Ameliorates Cardiac Dysfunction of Endotoxemic Rats

The mortality in septic patients with myocardial dysfunction is higher than those without it. Beneficial effects of flavonoid oroxylin A (Oro-A) on endotoxemic hearts were evaluated and compared with that of arginine vasopressin (AVP) which is used to reverse hypotension in septic patients. Endotoxe...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Liu, Chin-Hung, Chen, Mei-Fang, Tseng, Tzu-Ling, Chen, Lih-Geeng, Kuo, Jon-Son, Lee, Tony Jer-Fu
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3489109/
https://ncbi.nlm.nih.gov/pubmed/23193421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/408187
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!